Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans

Gastroenterology

Volumn 137, Issue 1, 2009, Pages

  Wasmuth, Hermann E ^a   Lammert, Frank ^b   Zaldivar, Mirko Moreno ^a   Weiskirchen, Ralf ^a   Hellerbrand, Claus ^c   Scholten, David ^a   Berres, Marie Luise ^a   Zimmermann, Henning ^a   Streetz, Konrad L ^a   Tacke, Frank ^a   Hillebrandt, Sonja ^b   Schmitz, Petra ^a   Keppeler, Hildegard ^b   Berg, Thomas ^d   Dahl, Edgar ^a   Gassler, Nikolaus ^a   Friedman, Scott L ^e   Trautwein, Christian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COLLAGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON; MESSENGER RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROGENESIS; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; STELLATE CELL; T LYMPHOCYTE; TH1 CELL;

EID: 67649183610     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.03.053     Document Type: Article

References (40)

1. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
2. Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol 214 (2008) 199-210
3. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134 (2008) 1655-1669
4. Missiha S.B., Ostrowski M., and Heathcote E.J. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 134 (2008) 1699-1714
5. Juran B.D., and Lazaridis K.N. Applying genomics to the study of complex disease. Semin Liver Dis 27 (2007) 3-12
6. Huang H., Shiffman M.L., Friedman S., et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 46 (2007) 297-306
7. Hillebrandt S., Wasmuth H.E., Weiskirchen R., et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet 37 (2005) 835-843
8. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
9. Heydtmann M., and Adams D.H. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 49 (2009) 676-688
10. Strieter R.M., Gomperts B.N., and Keane M.P. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117 (2007) 549-556
11. Hillebrandt S., Goos C., Matern S., et al. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123 (2002) 2041-2051
12. Hancock W.W., Lu B., Gao W., et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 192 (2000) 1515-1520
13. Wacholder S., Rothman N., and Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 513-520
14. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
15. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
16. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
17. Xu L., Hui A.Y., Albanis E., et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54 (2005) 142-151
18. Lasagni L., Francalanci M., Annunziato F., et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197 (2003) 1537-1549
19. Wiederholt T., von Westernhagen M., Zaldivar M.M., et al. Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Hum Immunol 69 (2008) 861-866
20. Jeong W.I., Park O., Radaeva S., et al. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44 (2006) 1441-1451
21. Weng H., Mertens P.R., Gressner A.M., et al. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol 46 (2007) 295-303
22. Bonacchi A., Romagnani P., Romanelli R.G., et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276 (2001) 9945-9954
23. Abiola O., Angel J.M., Avner P., et al. The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet 4 (2003) 911-916
24. Ren X., Kennedy A., and Colletti L.M. CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocytes in culture. Shock 17 (2002) 513-520
25. Schrage A., Wechsung K., Neumann K., et al. Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines. Hepatology 48 (2008) 1262-1272
26. Holt A.P., Haughton E.L., Lalor P.F., et al. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136 (2009) 705-714
27. Lang K.S., Georgiev P., Recher M., et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116 (2006) 2456-2463
28. Hokeness K.L., Deweerd E.S., Munks M.W., et al. CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol 81 (2007) 1241-1250
29. Muse M., Kane J.A., Carr D.J., et al. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis. Virology 382 (2008) 132-144
30. Jiang D., Liang J., Hodge J., et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114 (2004) 291-299
31. Nakaya I., Wada T., Furuichi K., et al. Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 107 (2007) e12-e21
32. Bodmer W., and Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40 (2008) 695-701
33. Shi Z., Wakil A.E., and Rockey D.C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94 (1997) 10663-10668
34. Pockros P.J., Jeffers L., Afdhal N., et al. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 45 (2007) 569-578
35. Zeremski M., Petrovic L.M., Chiriboga L., et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48 (2008) 1440-1450
36. Bieche I., Asselah T., Laurendeau I., et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 332 (2005) 130-144
37. Petrai I., Rombouts K., Lasagni L., et al. Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. Int J Biochem Cell Biol 40 (2008) 1764-1774
38. Datta D., Flaxenburg J.A., Laxmanan S., et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res 66 (2006) 9509-9518
39. von Hundelshausen P., Koenen R.R., Sack M., et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105 (2005) 924-930
40. Gao B., Jeong W.I., and Tian Z. Liver: an organ with predominant innate immunity. Hepatology 47 (2008) 729-736